These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 6475918)

  • 21. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of oral contraceptives and risk of breast cancer in young women.
    Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
    Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
    Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal and reproductive factors in melanoma risk.
    Osterlind A
    Clin Dermatol; 1992; 10(1):75-8. PubMed ID: 1504931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Female hormone utilisation and risk of hepatocellular carcinoma.
    Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
    Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of exogenous hormones hormones and risk of papillary thyroid cancer (Washington, United States).
    Rossing MA; Voigt LF; Wicklund KG; Williams M; Daling JR
    Cancer Causes Control; 1998 May; 9(3):341-9. PubMed ID: 9684714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of oral contraceptive use in northern Italy.
    La Vecchia C; Decarli A; Parazzini F; Gentile A; Negri E; Franceschi S
    Contraception; 1986 Aug; 34(2):145-56. PubMed ID: 3780230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer risk in relation to type of estrogen contained in oral contraceptives.
    Schlesselman JJ; Stadel BV; Murray P; Lai SH
    Contraception; 1987 Dec; 36(6):595-613. PubMed ID: 3446437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of oral contraceptive use and risk of breast cancer in women.
    Romieu I; Willett WC; Colditz GA; Stampfer MJ; Rosner B; Hennekens CH; Speizer FE
    J Natl Cancer Inst; 1989 Sep; 81(17):1313-21. PubMed ID: 2769784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.
    Sakoda LC; Horn-Ross PL
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):51-7. PubMed ID: 11815401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraceptives and endometrial cancer: do other risk factors modify the association?
    Stanford JL; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Hoover RN
    Int J Cancer; 1993 May; 54(2):243-8. PubMed ID: 8486426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of low-dose oral contraceptives and stroke in young women.
    Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.